Crohn's Disease Clinical Trials

32 studies are recruiting for crohn's disease in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

New York, New York 22 Orlando, Florida 13 Tyler, Texas 11 Atlanta, Georgia 10 Miami, Florida 10 Colorado Springs, Colorado 9 Houston, Texas 9 Indianapolis, Indiana 9 Philadelphia, Pennsylvania 9 Providence, Rhode Island 9 San Antonio, Texas 9 Boston, Massachusetts 8 Kissimmee, Florida 8 St Louis, Missouri 8 Tacoma, Washington 8 Los Angeles, California 7 Lubbock, Texas 7 Tampa, Florida 7 Liberty, Missouri 6 Morristown, New Jersey 6 Oklahoma City, Oklahoma 6 Phoenix, Arizona 6 San Diego, California 6 Seattle, Washington 6 Westlake, Ohio 6 Chapel Hill, North Carolina 5 Cleveland, Ohio 5 Dothan, Alabama 5 Las Vegas, Nevada 5 Little Rock, Arkansas 5 Louisville, Kentucky 5 Mansfield, Texas 5 Orange, California 5 Rochester, Minnesota 5 Southlake, Texas 5 Sun City, Arizona 5 Bellevue, Washington 4 Chicago, Illinois 4 Cincinnati, Ohio 4 Columbus, Ohio 4 Coronado, California 4 Dallas, Texas 4 Dayton, Ohio 4 Fayetteville, North Carolina 4 Fort Worth, Texas 4 Greenville, South Carolina 4 Gurnee, Illinois 4 Hartford, Connecticut 4 Hershey, Pennsylvania 4 Kansas City, Kansas 4 Kansas City, Missouri 4 Lancaster, California 4 Mentor, Ohio 4 Ogden, Utah 4 Palmetto Bay, Florida 4 Rochester, New York 4 Anaheim, California 3 Aurora, Colorado 3 Baton Rouge, Louisiana 3 Bridgeton, Missouri 3

Studies, page 2

  1. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

    This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Mirador Therapeutics Selected Site, Birmingham, Alabama
    Locations
    66 in total
    Run by
    Mirador Therapeutics, Inc.

    See if you can join NCT07113522 on ClinicalTrials.gov

  2. A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease

    The purpose of this research is to see if patients with Crohn's disease (CD) and abdominal pain resulting in health-related quality of life deficits despite lack of evidence of active inflammation improve with the use of virtual reality (VR).

    Stage
    Not phased
    Ages
    18 to 70
    Site
    Mayo Clinic Florida, Jacksonville, Florida
    Run by
    Mayo Clinic

    See if you can join NCT06647615 on ClinicalTrials.gov

  3. 68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease

    This study is a prospective, case-control study evaluating whether the PET radiotracer 68Ga-FAPI-46 can detect fibrostenosing Crohn's disease in the small bowel. The goal is to determine whether areas of early or developing fibrosis ("pre-stricture" changes) demonstrate uptake of the tracer, which …

    Stage
    EARLY_Phase 1
    Ages
    18 and older
    Site
    Mayo Clinic, Rochester, Minnesota
    Run by
    Mayo Clinic

    See if you can join NCT07273188 on ClinicalTrials.gov

  4. Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

    The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from individuals with brain inflammation and related neuroinflammatory conditions. Participants in the United States aged 2 years…

    Stage
    Not phased
    Ages
    2 and older
    Site
    Brain Inflammation Collaborative, Delafield, Wisconsin
    Run by
    Brain Inflammation Collaborative

    See if you can join NCT04806620 on ClinicalTrials.gov

  5. Autologous Stem Cell Transplantation for Crohn's Disease

    The objective of this study is to evaluate the safety and effectiveness of administering high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood stem cells (PBSC) in pediatric and adult patients with severe Crohn's disease.

    Stage
    Phase 1
    Ages
    10 to 60
    Site
    UPMC Prebyterian- Adult Gastroenterology, Pittsburgh, Pennsylvania
    Locations
    2 in total
    Run by
    Paul Szabolcs

    See if you can join NCT00692939 on ClinicalTrials.gov

  6. Helmsley 3.0: Abbreviated MRE

    The purpose of our study is to compare an abbreviated magnetic resonance imaging (MRI) of the bowel or magnetic resonance enterography (MRE) protocol to a conventional, standard of care MRE in children and adults with Crohn's Disease.

    Stage
    Not phased
    Ages
    10 and older
    Site
    Mayo Clinic, Rochester, Minnesota
    Locations
    2 in total
    Run by
    Children's Hospital Medical Center, Cincinnati

    See if you can join NCT06533228 on ClinicalTrials.gov

  7. Beta-Hydroxybutyrate Feasibility Treating IBD

    This clinical trial aims to understand the feasibility of patients taking ketone body supplement beta-hydroxybutyrate (BHB) for 4 weeks with a confirmed diagnosis of Crohn's disease and starting new therapy for active disease. The main questions it aims to answer are: * BHB supplementation will be …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Texas at Austin, Austin, Texas
    Run by
    University of Texas at Austin

    See if you can join NCT06351124 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.